Vanda Pharmaceuticals Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $101.4M | $603.6M | $66.9M |
| Jun 2022 | $100.6M | $609.1M | $58.2M |
| Sep 2022 | $106.1M | $621.8M | $49.4M |
| Dec 2022 | $107.0M | $634.2M | $135.0M |
| Mar 2023 | $108.8M | $644.5M | $354.2M |
| Jun 2023 | $101.8M | $641.7M | $150.0M |
| Sep 2023 | $98.5M | $641.6M | $183.2M |
| Dec 2023 | $103.5M | $648.4M | $135.8M |
| Mar 2024 | $108.7M | $652.7M | $125.2M |
| Jun 2024 | $108.9M | $651.4M | $103.0M |
| Sep 2024 | $103.9M | $645.1M | $100.5M |
| Dec 2024 | $117.7M | $656.2M | $102.3M |
| Mar 2025 | $120.5M | $631.9M | $111.8M |
| Jun 2025 | $138.4M | $624.7M | $81.0M |
| Sep 2025 | $135.1M | $601.1M | $70.0M |
| Dec 2025 | $161.8M | $488.9M | $84.9M |
| Mar 2026 | $152.8M | $433.5M | $54.0M |
| Jun 2026 | $192.3M | $412.5M | $55.9M |